Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Amberstone Biosciences
company
About
Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.05M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships.Amberstone's focus is difficult targets requiring a unique mode-of-action and/or particular functional property, which are otherwise challenging for traditional approaches.These conventional limitations are overcome via a two-pronged approach. First, we have demonstrated success with our microfluidics-powered AmberFlow drug-discovery platform. Second, our team of experts has keen insights in immuno-oncology and ample experience with single-cell assay biology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.27M
Amberstone Biosciences has raised a total of
$1.27M
in funding over 2 rounds. Their latest funding was raised on
Apr 12, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 12, 2021 | Grant | $1.05M | 1 |
National Science Foundation
|
— | Detail |
| Aug 29, 2019 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Amberstone Biosciences is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
